Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease

doi:10.3748/wjg.v20.i24.7730

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8860)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

696

WORD

260

HTML

5734

Figures (1-4)

166

Tables (1-2)

147

Sum=7003

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

991

Download

866

Sum=1857

Jun 28, 2014 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (65)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 28, 2014; 20(24): 7730-7738
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7730

Full Size Figure Download Figure

Figure 3 Stretta is an adjunct in the treatment of gastroesophageal reflux disease that spans the “gap” between proton pump inhibitor responders and surgical candidates. PPI: Proton pump inhibitor; ARS: Anti-reflux surgery; “gap”: % of patients refractory to PPI not pursuing ARS.

Citation: Triadafilopoulos G. Stretta: A valuable endoscopic treatment modality for gastroesophageal reflux disease. World J Gastroenterol 2014; 20(24): 7730-7738
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7730.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7730